Search results for: 'Complex Drug'

The medical imaging and informatics industry is evolving, with vendors launching new products and solutions every other day. As the reimbursement environment transitions from fee-for-service to value-based payment, vendors business models and value propositions are changing. New evidence on the use of specific imaging techniques is influencing chan...

06 Jul 2023  |  Global  |  Market Research

Global Animal Feed Phytogenics Growth Opportunities

Rising Regulatory Bans on Antibiotic Growth Promoters (AGP) Enable Market Expansion

Infographics

×

Increasing antimicrobial resistance in pathogenic bacteria has resulted in many countries banning AGPs for animal nutrition. Growing concerns worldwide over AGPs in animal nutrition have resulted in efforts to use alternative ingredients that can effectively replace AGPs; phytogenics is one such alternative. Our analysis shows that Europe domin...

The laboratory automation market refers to the use of various technologies, software, and equipment to automate laboratory processes and workflows. This market includes a broad range of products and solutions that help laboratories improve their productivity, accuracy, and efficiency while reducing the risk of errors and improving data quality. A...

The opportunities that come with the utilization of quantum sensing technology in healthcare demonstrate significant potential to revolutionize diagnostics, personalized medicine, and drug development. Quantum sensors offer superior sensitivity and precision, enabling earlier disease detection, easier and non-intrusive monitoring, and producing bet...

Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...

Rare diseases pose a global burden to healthcare despite making up a very small fraction of the global disease landscape. Most treatment options for rare diseases focus on maintaining the disease symptoms, rather than a disease-modifying approach. To address this unmet need, RNA therapies are emerging as disease-modifying approaches addressing the ...

Frost & Sullivan expects Northrop Grumman to continue enhancing its security-centric portfolio, focusing on the development of cybersecurity and communications solutions. The company works closely with national governments to deliver large-scale, complex, and technologically advanced solutions. Increasing demand from non-governmental customers may ...

The research analyzes growth opportunities and current trends in the Hardware-in-loop (HIL) market. The increasing complexity of electronic assembly and of product safety has bolstered the demand for HIL simulation testing. This research includes detailed analysis into selective HIL applications, such as automotive, aerospace and defense (A&D) and ...

The move to the cloud and hybrid workspaces have become the business norm, and the management of user, machine, and workload identities requires a cloud-native and cloud-first approach. In an environment of ever-more-complex hybrid and multicloud architectures, security concerns and use cases, limitations due to certificate issuance and PKI managem...